ImmunityBio, Inc.

IBRX

Exchange: Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0001326110

SEC filings (opens in a new tab)

No open-market purchases or sales by ImmunityBio, Inc. insiders were filed in the last 90 days; 405 institutions reported holding it in 13F filings for Q2 2026, worth $1.76B in total; no superinvestor holds it.

Q4 2023 vs. Q3 2023

How the institutions holding ImmunityBio, Inc. changed between Q3 2023 and Q4 2023.

All holders in Q4 2023 All holders in Q3 2023

13F holders of IBRX: Q3 2023 compared with Q4 2023
Measure	Q3 2023	Of which not filed for Q4 2023	Q4 2023	Change
Holders	132	1	148	+17
Shares	49.9M	10.2K	57.5M	+7.69M (+15.4%)
Value	$84.1M	$17.2K	$288.9M	+$204.8M (+243.5%)

1 institution that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so the changes leave them out.

New holders (30)

Institutions that held ImmunityBio, Inc. at the end of Q4 2023 but not at the end of Q3 2023.

Institutions new to IBRX in Q4 2023
Institution	Shares	Value	% of portfolio
Jane Street Group, LLC	821,643	$4.12M	0.01%
Rafferty Asset Management, LLC	739,808	$3.71M	0.02%
D. E. Shaw & Co., Inc.	591,101	$2.97M	0.00%
Putnam Investments LLC	534,201	$2.68M	0.00%
Erste Asset Management GmbH	153,000	$797.1K	0.01%
Profund Advisors LLC	119,957	$602.2K	0.03%
Virtu Financial LLC	60,469	$304.0K	0.02%
Squarepoint Ops LLC	55,322	$277.7K	0.00%
E Fund Management Co., Ltd.	39,494	$198.3K	0.01%
Bell & Brown Wealth Advisors, LLC	34,400	$172.7K	0.08%
Stratos Wealth Partners, LTD.	34,050	$170.9K	0.00%
Creative Planning	31,638	$158.8K	0.00%
ExodusPoint Capital Management, LP	23,558	$118.0K	0.00%
Continuum Advisory, LLC	21,243	$107.4K	0.02%
Ameriprise Financial Inc	21,100	$105.9K	0.00%
Carlson Capital Management	17,600	$88.4K	0.00%
Copperwynd Financial, LLC	15,700	$78.8K	0.03%
Courier Capital LLC	15,000	$75.3K	0.01%
Planning Capital Management Corp	13,342	$67.0K	0.05%
Axq Capital, LP	12,400	$62.2K	0.02%
Gotham Asset Management, LLC	10,788	$54.2K	0.00%
Private Advisor Group, LLC	10,500	$52.7K	0.00%
Susquehanna Portfolio Strategies, LLC	10,392	$52.2K	0.00%
Commonwealth Equity Services, LLC	10,185	$51.0K	0.00%
Meridian Management Co	10,000	$45.8K	0.01%
Advisory Services Network, LLC	2,506	$12.6K	0.00%
Mayo Clinic	1,403	$7.04K	0.04%
Central Trust Co	1,000	$5.02K	0.00%
EverSource Wealth Advisors, LLC	723	$3.63K	0.00%
MeadowBrook Investment Advisors LLC	200	$1.00K	0.00%

Sold out (13)

Institutions that held ImmunityBio, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.

Institutions that sold out of IBRX in Q4 2023
Institution	Shares, Q3 2023	Value, Q3 2023
Armistice Capital, LLC	3,476,000	$5.87M
National Bank of Canada	699,300	$1.07M
Group One Trading, L.P.	446,743	$755.0K
CVI Holdings, LLC	226,916	$383.5K
Stonehage Fleming Financial Services Holdings Ltd	85,000	$143.7K
Verition Fund Management LLC	84,770	$143.3K
Point72 Asset Management, L.P.	15,500	$26.2K
Winton Group Ltd	15,438	$26.1K
Engineers Gate Manager LP	13,632	$23.0K
Moss Adams Wealth Advisors LLC	12,341	$20.9K
Sigma Planning Corp	11,050	$18.7K
US Bancorp	1,710	$2.89K
Parallel Advisors, LLC	1,000	$1.69K

Not filed for Q4 2023 yet (1)

Institutions that held ImmunityBio, Inc. at the end of Q3 2023 and haven't filed a 13F for Q4 2023. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding IBRX in Q3 2023 that haven't filed for Q4 2023
Institution	Shares, Q3 2023	Value, Q3 2023
Quantamental Technologies LLC	10,156	$17.2K